D-0529-2026 Class II Ongoing

Recalled by Huons Co., Ltd. — Jecheon, N/A

FDA drug recall D-0529-2026 was initiated by Huons Co., Ltd. on Apr 2, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 33,599,925 ampules and 23658125 vials.

Recall details

Product Type
Drugs
Report Date
Apr 22, 2026
Initiation Date
Apr 2, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
33,599,925 ampules and 23658125 vials

Product description

Lidocaine HCl injection, USP, 1% 50mg/5mL (10 mg/mL), 5 mL Single Dose Vials, Rx only, Manufactured by: Huons Co, Ltd, Chungcheongbuk-do, Korea NDC 73293-0001-1 (vial), NDC 73293-0001-2 (10 count carton); Distributed by: McKesson Corporation, dba Sky Packaging, NDC 63739-170-13 (vials), NDC 63739-170-24 (10 count cartons) and NDC 63739-170-27 (25 count cartons); Distributed by: Brookefield Pharmaceuticals, LLC, Brookefield, WI, Manufactured by: Huons Co., Ltd., 100 Bio valley-ro, Jecheon-si, Chungchengbuk-do, Korea, NDC 71351-021-05 (vials), NDC 71351-021-10 (10 count cartons), NDC 71351-021-25 (25 count cartons); Distributed by Novagenix Labs LLC, Morrisville, NC NDC 84769-0001-1 (vials), NDC 84769-0001-2 (10 count carton)

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

USA Nationwide.

Code information

All lots within expiry

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0529-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0529-2026. Report a data issue: hello@regdatalab.com.